Literature DB >> 24978424

Optical coupling control: an important step toward better shockwave lithotripsy.

Geert G Tailly1, Martine M Tailly-Cusse.   

Abstract

BACKGROUND: In modern "dry" lithotripters, shockwaves are generated in a membrane-covered water cushion that is then coupled to the patient.To limit energy loss, a coupling agent, usually ultrasound gel, is used in this acoustic interface. During the coupling process, air pockets are inevitably trapped in the coupling area, which subsequently remains invisible to the operator. These air pockets dramatically decrease stone fragmentation efficiency up to 40%.
MATERIALS AND METHODS: To check for air bubbles in the coupling interface, a video camera was installed in the therapy head of our Dornier Gemini lithotripter: all air bubbles observed in the coupling zone could then be removed under visual control. We evaluated the effect of this optically controlled coupling (OCC) on treatment results (10/1/12-9/30/13) and compared these to the results obtained in a "blind" coupling mode (4/1/11-4/30/12).
RESULTS: Optically controlled removal of air bubbles from the coupling area reduced the required number of shockwaves with 25.4% for renal stones and 25.5% for ureteral stones. Energy level was reduced by 23.1% for renal stones and by 22.5% for ureteral stones. For renal stones, total applied energy was thus reduced by 42.9%. Effectiveness quotients were comparable.
CONCLUSIONS: Optical control with a video camera proved pivotal in the realization of bubble-free coupling. Bubble-free coupling significantly reduced the total energy needed to obtain comparable treatment results. Theoretically, this should also lead to a reduced incidence and severity of shockwave-induced adverse effects. We consider this an important step toward better and safer shockwave lithotripsy and would therefore advocate the standard incorporation of an OCC system in all new lithotripters.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24978424     DOI: 10.1089/end.2014.0338

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  8 in total

Review 1.  Arguments for choosing extracorporeal shockwave lithotripsy for removal of urinary tract stones.

Authors:  Hans-Göran Tiselius; Christian G Chaussy
Journal:  Urolithiasis       Date:  2015-08-28       Impact factor: 3.436

Review 2.  Engineering Better Lithotripters.

Authors:  Christian G Chaussy; Hans-Göran Tiselius
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

Review 3.  Clinical application of the therapeutic ultrasound in urologic disease: Part II of therapeutic ultrasound in urology.

Authors:  Minh-Tung Do; Tam Hoai Ly; Min Joo Choi; Sung Yong Cho
Journal:  Investig Clin Urol       Date:  2022-05-16

4.  A new optical coupling control technique and application in SWL.

Authors:  Jian Lin Lv
Journal:  Urolithiasis       Date:  2016-03-29       Impact factor: 3.436

Review 5.  [What is the current status of shock wave lithotripsy?]

Authors:  A Neisius
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

Review 6.  Clinical significance of residual fragments in 2015: impact, detection, and how to avoid them.

Authors:  Simon Hein; Arkadiusz Miernik; Konrad Wilhelm; Fabian Adams; Daniel Schlager; Thomas R W Herrmann; Jens J Rassweiler; Martin Schoenthaler
Journal:  World J Urol       Date:  2015-10-23       Impact factor: 4.226

7.  Contemporary treatment trends for upper urinary tract stones in a total population analysis in Germany from 2006 to 2019: will shock wave lithotripsy become extinct?

Authors:  Roman Herout; Martin Baunacke; Christer Groeben; Cem Aksoy; Björn Volkmer; Marcel Schmidt; Nicole Eisenmenger; Rainer Koch; Sven Oehlschläger; Christian Thomas; Johannes Huber
Journal:  World J Urol       Date:  2021-08-28       Impact factor: 4.226

8.  A clinical observational study of effectiveness of a solid coupling medium in extracorporeal shock wave lithotripsy.

Authors:  Hao-Han Chang; Yu-Chih Lin; Ching-Chia Li; Wen-Jeng Wu; Wen-Chin Liou; Yusen Eason Lin; Kuo-Kuang Huang; Wei-Chuan Chen
Journal:  BMC Urol       Date:  2022-04-12       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.